Retrospective Comparison of Patients Evaluated for Pediatric Autoimmune Encephalitis with Typical and Atypical Premorbid Neuropsychiatric Development.
A sudden burst of new problems in a delayed child may be autoimmune encephalitis, not regular autism progression.
01Research in Context
What this study did
Doctors looked back at kids who were tested for autoimmune encephalitis. They split them into three groups: typically developing, neurodevelopmental delay, and neurodevelopmental delay plus encephalitis. They counted how many problem areas each child had. They also checked if the kids got better after treatment.
What they found
Kids with neurodevelopmental delay plus encephalitis showed more problem areas than kids with only neurodevelopmental delay. Treatment helped both typical and delayed kids about the same. A sudden jump in many skills or behaviors can be a warning sign.
How this fits with other research
Yanai et al. (2025) found that viral brain infections raise later autism risk by 40%. Kira’s team now shows that the reverse also happens: already-delayed kids can suddenly worsen from autoimmune encephalitis.
Ben-Arie et al. (2025) spotted brain swelling on MRI in one-third of toddlers who later got autism. Kira adds a clinical clue: if a delayed child suddenly gains many new problems, think autoimmune, not just new ASD traits.
Newcomb et al. (2025) showed that typical preschoolers still act out daily. Kira’s work says look at the speed of change, not just the level—an overnight spike is the red flag.
Why it matters
You already track gradual skill loss in autism. Add one quick screen: ask parents, “Did several new behaviors pop up within days or weeks?” If yes, talk to the pediatrician about autoimmune encephalitis testing. Early steroids or IVIG can stop damage and give you back the child you knew last month.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one parent question to your intake: “Did you see many new behaviors start fast?” Note ‘yes’ for medical referral.
02At a glance
03Original abstract
PURPOSE: Patients with neurodevelopmental disorders (NDD) (i.e. autism, developmental delay, early-onset psychiatric or seizure disorders) increasingly seek evaluation of new or exacerbated symptoms concerning for autoimmune encephalitis (AE). Clinical AE evaluation can be challenging in NDD patients with symptom overlap between anti-neuronal autoimmunity and baseline atypical neurodevelopment. This study sought to explore differences in AE features by neurodevelopmental status. METHODS: This retrospective chart review included 67 children with typical development (TD) or NDD evaluated for AE at the authors' institution. AE diagnosis included seronegative AE or seropositive AE with anti-NMDAR or anti-GAD antibodies. Reported AE clinical domains, symptom onset acuity, and treatment response were compared between three groups: (1) TD children with AE (TD-AE, N = 24); (2) NDD children with AE (NDD-AE, N = 21); and (3) NDD children with a non-AE diagnosis following appropriate workup (NDD-nonAE, N = 22). RESULTS: Children with AE had a greater number of reported clinical domains than non-AE children with NDD (p < 0.0001) regardless of baseline developmental status. There were no observed differences in reported domains between TD-AE and NDD-AE groups. Onset acuity differed across the three groups (p = 0.04). No treatment response differences were observed between groups. CONCLUSION: NDD children with AE had a comparable number of reported clinical domains relative to TD children and a similar treatment response. NDD patients with AE had a greater number of reported clinical domains than their NDD peers without an AE diagnosis. These findings suggest that AE is a multi-domain process in both TD and NDD children.
Journal of autism and developmental disorders, 2025 · doi:10.3389/fpsyt.2021.775017